GE HealthCare CEO Peter Arduini has highlighted the company’s disciplined approach to M&A in order to “fill gaps and add tuck-ins” to its portfolio, while also operating as a company that is well-positioned to advance its portfolio through organic investment and product development.
Arduini reflected on the approach, using the company’s recent acquisition of medical imaging software provider Intelerad to contextualise his views, at this year’s J.P. Morgan Healthcare Conference in San Francisco, held from 12 to 15 January.
GE HealthCare moved to acquire Intelerad in a $2.3bn agreement in November 2025, with the transaction expected to close in H1 2026.
For GE HealthCare, Arduini said the Canadian company will deliver a cloud-first, artificial intelligence (AI) enablement for imaging in an ecosystem.
AI is having a profound influence on the healthcare space, with the technology’s application especially pronounced in the medical imaging space as a means to streamline efficiencies and glean deeper insights into the likes of CT scans and sonograms. According to GlobalData analysis, AI in healthcare is forecast to reach a $19bn valuation by 2027.
Looking at the imaging marketplace today, while there are in- and out-patient solutions, regarding an integrated enterprise approach for imaging, Arduini stated that there is not really a full platform solution that can orchestrate and execute AI applications that is not made by GE HealthCare.
“They could be made by us. They could be developed in-house. They could be third-party applications; whatever the case, they enhance workflows,” Arduini continued.
“We think Intelerad is going to be a great tuck-in fit for GE HealthCare in this regard, and an important part of our precision care journey,” Arduini concluded.
The deal for Intelerad came in the same month GE HealthCare revealed total Q3 revenues of $5.1bn, up 4% in organic growth compared to the same period in 2024. This led the company to raise its 2025 guidance.
Another talking point in Arduini’s J.P. Morgan presentation surrounded the steps GE HealthCare has taken to simplify its CT portfolio. Arduini highlighted that in recent years, the company’s CT portfolio has been slimmed down from ‘roughly’ 15-16 configurations and 10 tables down to three in recent years, with the aim to reduce complexity for customers and lower internal costs.
Summing up GE Healthcare’s forward outlook, Arduini shared that over time, the company wants to be measured less as an imaging hardware vendor, and as more of a healthcare solutions provider.
Sign up here to receive daily updates on the latest healthcare industry trends emerging from the JP Morgan Healthcare Conference 2026.
Sign up here to receive a comprehensive report after the conference.
